Treating osteoporosis in post-menopausal women: a case approach

Cleve Clin J Med. 2004 Oct;71(10):829-37. doi: 10.3949/ccjm.71.10.829.

Abstract

We now have several agents of different classes for treating postmenopausal osteoporosis. In this paper, a case report serves as the focus for a discussion of the risk factors for postmenopausal osteoporosis and of the available therapies.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Alendronate / therapeutic use
  • Densitometry
  • Diphosphonates / therapeutic use*
  • Etidronic Acid / analogs & derivatives*
  • Etidronic Acid / therapeutic use
  • Female
  • Humans
  • Mass Screening
  • Middle Aged
  • Osteoporosis, Postmenopausal / diagnosis
  • Osteoporosis, Postmenopausal / drug therapy*
  • Raloxifene Hydrochloride / therapeutic use
  • Risedronic Acid
  • Risk Factors
  • Selective Estrogen Receptor Modulators / therapeutic use*
  • Treatment Outcome

Substances

  • Diphosphonates
  • Selective Estrogen Receptor Modulators
  • Raloxifene Hydrochloride
  • Risedronic Acid
  • Etidronic Acid
  • Alendronate